Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Phio Pharmaceuticals Corp (NQ: PHIO ) 3.211 +0.031 (+0.98%) Streaming Delayed Price Updated: 11:00 AM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 9,929 Open 3.180 Bid (Size) 3.160 (1) Ask (Size) 3.280 (1) Prev. Close 3.180 Today's Range 3.170 - 3.280 52wk Range 0.5000 - 6.195 Shares Outstanding 860,721 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series October 02, 2024 Presentation and live Q&A to take place Wednesday, October 9, 2024, at 2 PM EDTMarlborough, Massachusetts--(Newsfile Corp. - October 2,... Via Newsfile Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference October 01, 2024 Marlborough, Massachusetts--(Newsfile Corp. - October 1, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary... Via Newsfile Performance YTD +317.21% +317.21% 1 Month +21.64% +21.64% 3 Month +452.91% +452.91% 6 Month +358.82% +358.82% 1 Year +111.28% +111.28% More News Read More INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society September 25, 2024 Via Newsfile Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series September 17, 2024 Via Newsfile PHIO Stock Earnings: Phio Pharma Reported Results for Q1 2024 May 09, 2024 Via InvestorPlace Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA September 16, 2024 Via Newsfile Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 09, 2024 Via Newsfile Topics Intellectual Property Exposures Intellectual Property Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series August 29, 2024 Via Newsfile PHIO Stock Earnings: Phio Pharma Misses EPS for Q2 2024 August 14, 2024 Via InvestorPlace Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update August 14, 2024 Via Newsfile Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio's Patented INTASYL Compound August 06, 2024 Via Newsfile Topics Intellectual Property Exposures Intellectual Property Phio Pharmaceuticals Announces New Chief Financial Officer August 01, 2024 Via Newsfile Topics Initial Public Offering Exposures Securities Market Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session July 29, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday July 29, 2024 Via InvestorPlace Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket July 29, 2024 Via Benzinga Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds July 12, 2024 Via Newsfile Topics Regulatory Compliance Exposures Legal Regulatory Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762 July 08, 2024 Via Newsfile Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds July 05, 2024 Via Newsfile Phio Pharmaceuticals Announces Reverse Stock Split July 02, 2024 Via Newsfile Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging June 18, 2024 Via Newsfile Topics Intellectual Property Exposures Intellectual Property Phio Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying June 12, 2024 Via Benzinga Sypris Solutions And 3 Other Stocks Under $2 Insiders Are Buying June 11, 2024 Via Benzinga Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b Clinical Study of Phio's Lead Compound PH-762 May 28, 2024 Via Newsfile Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO) May 23, 2024 Via Newsfile Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update May 09, 2024 From Phio Pharmaceuticals Corp. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
